Tom Sabia, MBA Managing Director
Coverage Area
Outsourced Pharma Services
The Braff Group is delighted to launch coverage of Outsourced Pharma Services—one of the most sought-after sectors in health care M&A
As drug development and commercialization become increasingly complex and capital-intensive, pharmaceutical sponsors are strategically outsourcing key stages of the process. From clinical trial sites, CROs, and functional service providers to commercial partners and tech-enabled solutions, investors are racing to acquire high-quality platforms across the full drug development lifecycle. This surge in consolidation is driving heightened competition and record valuations.
To lead this new vertical, The Braff Group welcomes Tom Sabia, a 25-year veteran of pharmaceutical drug development. Tom brings extensive experience partnering with pharma and biotech organizations on outsourcing initiatives, M&A, and commercialization strategies.
With more than 27 years and nearly 400 completed transactions in health care services M&A, The Braff Group is uniquely positioned to help outsourced pharma service companies maximize their value in this dynamic and rapidly expanding market.
Outsourced Pharma Services Director
Recent Braff Reports
Outsourced Pharma Services: Focus on Clinical Services
As the market stands today, if you ask a health care investor which areas they are targeting, you’ll likely hear...
Read MoreTake the Next Step with The Braff Group
Don’t sell yourself short.